Irisin in thyroid diseases.

Autor: Chen Q; Department of outpatient, Shijiazhuang No.8 Retired Cadre Retirement Home of Hebei Military Region, Shijiazhuang 050000, China., Wang J; Department of Cardionephrology, Hospital affiliated to NCO School of Army Military Medical University, Shijiazhuang 050000, China., Li K; Department of oncology, hematology and endocrinology, Hospital affiliated to NCO School of Army Military Medical University, Shijiazhuang 050000, China., Luan JQ; Clinical laboratory, Hospital affiliated to NCO School of Army Military Medical University, Shijiazhuang 050000, China., Li JM; Department of oncology, hematology and endocrinology, Hospital affiliated to NCO School of Army Military Medical University, Shijiazhuang 050000, China., Wang YT; Department of oncology, hematology and endocrinology, Hospital affiliated to NCO School of Army Military Medical University, Shijiazhuang 050000, China. Electronic address: yatingwangwytf@126.com.

Publikováno v: Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2025 Jan 01; Vol. 564, pp. 119929. Date of Electronic Publication: 2024 Aug 21.

Quantitative anti-HBc combined with quantitative HBsAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NA-suppressed chronic hepatitis B patients.

Autor: Wang WX; Peking University 302 Clinical Medical School, Beijing, China.; Senior Department of Infectious Diseases, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.; Medical School of Chinese People's Liberation Army (PLA), Beijing, China., Jia R; Senior Department of Infectious Diseases, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.; Medical School of Chinese People's Liberation Army (PLA), Beijing, China., Gao YY; Senior Department of Infectious Diseases, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China., Liu JY; Senior Department of Infectious Diseases, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China., Luan JQ; Senior Department of Infectious Diseases, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China., Qiao F; Senior Department of Infectious Diseases, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China., Liu LM; Senior Department of Infectious Diseases, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China., Zhang XN; Senior Department of Infectious Diseases, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China., Wang FS; Peking University 302 Clinical Medical School, Beijing, China.; Senior Department of Infectious Diseases, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.; Medical School of Chinese People's Liberation Army (PLA), Beijing, China., Fu J; Peking University 302 Clinical Medical School, Beijing, China.; Senior Department of Infectious Diseases, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.; Medical School of Chinese People's Liberation Army (PLA), Beijing, China.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Jul 26; Vol. 13, pp. 894410. Date of Electronic Publication: 2022 Jul 26 (Print Publication: 2022).

[Early reduction of serum RANTES can predict HBsAg clearance in patients with chronic hepatitis B treated with nucleos(t)ide analogues combined with peginterferon alpha].

Autor: Jia R; Medical School of Chinese PLA, Beijing 100853, China Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China., Wang WX; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China Peking University 302 Clinical Medical School, Beijing 100039, China., Gao YY; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China., Luan JQ; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China., Qiao F; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China., Liu JY; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China., Yuan JH; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China., Cheng YQ; Department of Geriatric Medicine, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China., Wang FS; Medical School of Chinese PLA, Beijing 100853, China Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China Peking University 302 Clinical Medical School, Beijing 100039, China., Fu JL; Medical School of Chinese PLA, Beijing 100853, China Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China Peking University 302 Clinical Medical School, Beijing 100039, China.

Publikováno v: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2021 Jul 20; Vol. 29 (7), pp. 666-672.